Ocugen Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$1.41

+0.02 (+1.44%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +2,025.5% upside

Low Target $22.68

Average Target $29.97

High Target $39.58

Current Price $1.41

Current
$1.41

Target
$29.97

$22.68 $29.97 avg $39.58

Scenario Analysis

Bear Case

$22.68

1,508.5%

Low target

Base Case

$29.97

+2,025.5%

Avg target

Bull Case

$39.58

+2,707.1%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.73

-48.3% from high

52-Week Low

$0.90

+56.1% from low

Target vs 52W High

$29.97

+999.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-46.4%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+191.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.5%